Literature DB >> 3875418

Characterization of corticosteroid receptors in natural killer cells: comparison with circulating lymphoid and myeloid cells.

P Katz, A M Zaytoun, J H Lee.   

Abstract

Lymphocytes mediating natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) activities are relatively refractory to the changes in circulatory traffic and intrinsic function induced in other cell types by in vivo and in vitro corticosteroids (CS). To investigate if such drug resistance could be attributed to differences in the CS receptor number of affinity (Kd) of these cells, these characteristics were determined in purified populations of large granular lymphocytes (LGL), monocytes, neutrophils (PMN), and T cells. All cell types displayed a single class of CS receptor of uniform affinity; however, LGL resembled monocytes and PMN in receptor number and Kd while T cells had significantly fewer sites per cell with lower Kd. These studies suggest that the unresponsiveness of NK activity to CS is not secondary to differences in CS receptor capacity or affinity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875418     DOI: 10.1016/0008-8749(85)90258-8

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  3 in total

Review 1.  Exercise and natural killer cells. What is the relationship?

Authors:  L T Mackinnon
Journal:  Sports Med       Date:  1989-03       Impact factor: 11.136

2.  Corticosteroid-interleukin 2 interactions: inhibition of binding of interleukin 2 to interleukin 2 receptors.

Authors:  H J Horst; H D Flad
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

3.  Glucocorticoid receptors in mononuclear blood cells and their correlation to endogenous and exogenous corticoids in healthy and asthmatic children.

Authors:  M Griese; G Kusenbach; K Lüsebring; W Köster; B Roth; D Reinhardt
Journal:  Eur J Pediatr       Date:  1988-06       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.